Market Trends of Ear Infection Treatment Industry
This section covers the major market trends shaping the Ear Infection Treatment Market according to our research experts:
The Middle Ear Infection Segment is Expected to Show a High Growth Rate During the Forecast Period
An ear infection, called acute otitis media (AOM), is an infection of the middle ear—the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Children are more likely than adults to get ear infections. Factors such as the rise in infections in the middle ear and the increase in research and development in the therapy for middle ear infections are anticipated to boost market growth. For instance, as per the study published in May 2021 by the NIH, ear infections are among the most common illnesses in US children. They occur when bacteria or viruses infect the area behind the eardrum, called the middle ear. Parts of the middle ear become swollen or blocked, trapping fluid behind the eardrum, leading to pressure and pain and affecting hearing.
Furthermore, a study published in June 2021 by the NPJ journal stated that researchers developed a compact, three-dimensional (3-D)-printed microplasma jet array device as a treatment tool for Otitis Media Treatment. Additionally, in February 2021, the University of California, Irvine, sponsored a clinical study to assess the eardrum via direct visualization using an otoscope. Researchers can use LED-based multi-wavelength light absorption and scattering measurements for the analysis of the eardrum and the middle ear.
Furthermore, in February 2022, Cochlear Limited sponsored a clinical study with Trium Clinical Consulting and Suministros Hospitalarios Medical Group to evaluate the standard of care of participants with chronic Otitis Media Treatment who have already undergone a first middle ear surgery but still have at least moderate hearing loss.
However, major causes of hearing loss include congenital or early-onset childhood hearing loss, chronic middle ear infections, and noise-induced hearing loss. Hence, the rise in the prevalence of disabling hearing loss is also expected to be a driving factor for the market. For instance, as per the NIDCD 2021 update, about 2% of adults aged 45 to 54 have disabling hearing loss. The rate increases to 8.5% for adults aged 55 to 64. Nearly 25% of those aged 65 to 74 and 50% of those who are 75 and older have disabling hearing loss. Hence, considering the rise in middle ear infections and the increase in research studies associated with the development of middle ear infection treatment, it is anticipated that the studied segment will witness growth in the Ear Infection Treatment Market over the forecast period.
North America is Expected to Witness a Growth in the Ear Infection Treatment Market Over the Forecast Period
North America is anticipated to witness growth in the Ear Infection Treatment Market owing to factors such as a rise in the number of Ear Infections and increasing product launches for treating ear infections. According to a March 2021 article published by the National Institute on Deafness and Other Communication Disorders, five out of every six children in the country have an ear infection by the age of three. Thus, the high incidence rate of Pediatric Ear Infection in the country is projected to drive the market.
Furthermore, according to the NLM update in January 2022, Otitis Media is most commonly seen between 6 and 24 months. Approximately 80% of all children experience a case of otitis media during their lifetime, and between 80% and 90% of all children will have otitis media with an effusion before school age.
Furthermore, the rise in research and development in the field of ear infections is anticipated to boost market growth over the forecast period. For instance, in January 2021, Rochester General Hospital in New York sponsored and conducted a clinical study to identify the dynamic changes in nasopharyngeal (NP) colonization patterns and acute Otitis Media (AOM) etiology involving antibiotic-resistant Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu). Moreover, as per the August 2021 update from the NIH, the United States had nearly 20 million estimated cases of acute middle ear infections, and the annual cost associated with this condition is estimated to exceed USD 4 billion in 2021. Hence, due to the rise in Ear Infections and the increase in research and development in ear infection treatments, North America is anticipated to witness growth in the studied market over the forecast period.
